Diagnostic options · UAE

Liquid Biopsy tests in Dubai & UAE

Compare available Liquid Biopsy tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,500.00–21,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Liquid Biopsy test prices

Showing 1–5 of 5 matching tests.

Liquid Biopsy diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2425 Liquid Biopsy Circulating-Free DNA EGFR Mutation Test This test identifies and quantifies specific mutations in the EGFR gene using circulating-free DNA from a blood sample.	Peripheral Whole Blood	3 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR driver mutations", "Allele frequency"] Parameters [{"name": "EGFR Mutation Detection", "reference_range": "Detected/Not Detected"}] Preparation [] Indications ["Monitoring treatment response in EGFR-mutated cancers", "Detecting emergent resistance mutations (e.g., T790M)", "Guiding targeted therapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 92819-2 ICD-10: Z15.0 Clinical summary This test identifies and quantifies specific mutations in the EGFR gene using circulating-free DNA from a blood sample.
TEST-529 Liquid Biopsy Colon Cancer Test This test evaluates circulating tumor DNA (ctDNA) in blood for genetic mutations associated with colorectal cancer.	Peripheral whole blood	21 Working Days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Circulating tumor DNA (ctDNA)", "Actionable mutations (KRAS, NRAS, BRAF)", "Microsatellite Instability (MSI) status"] Parameters [{"name": "KRAS Mutation Status", "reference_range": "Negative/Positive"}, {"name": "NRAS Mutation Status", "reference_range": "Negative/Positive"}, {"name": "BRAF Mutation Status", "reference_range": "Negative/Positive"}, {"name": "MSI Status", "reference_range": "Stable/Unstable"}] Preparation ["No fasting required", "Ensure hydration", "Provide relevant clinical records"] Indications ["Detection of actionable mutations in colorectal cancer", "Monitoring disease progression", "Assessing treatment response", "Detecting minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 94135-0 ICD-10: C18.9, C19, C20 Clinical summary This test evaluates circulating tumor DNA (ctDNA) in blood for genetic mutations associated with colorectal cancer.
TEST-511 Liquid Biopsy Lung Cancer Test (NGS Panel) This test identifies actionable genetic mutations in cell-free DNA (ctDNA) from a blood sample to guide lung cancer treatment.	Peripheral blood (plasma ctDNA)	21 working days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Actionable mutations in ctDNA", "EGFR", "ALK", "ROS1", "BRAF", "KRAS", "MET"] Parameters [] Preparation ["No specific fasting required", "Inform laboratory of recent blood transfusion or surgery"] Indications ["Guiding targeted therapy for lung cancer", "Monitoring treatment response", "Detecting resistance mutations"] Measurement technique Confirm with laboratory Codes LOINC: 94498-5 ICD-10: C34.9 Clinical summary This test identifies actionable genetic mutations in cell-free DNA (ctDNA) from a blood sample to guide lung cancer treatment.
TEST-2817 OncoPro Liquid Biopsy Test This test analyzes circulating tumor DNA (ctDNA) in a blood sample using Next Generation Sequencing (NGS) to provide a genomic profile for cancer management.	Whole Blood	35 working days	21,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Circulating Tumor DNA (ctDNA)", "Genomic Mutations"] Parameters [] Preparation [] Indications ["Guiding targeted cancer therapy", "Monitoring treatment response", "Cancer diagnosis (in specific contexts)", "Patients with confirmed cancer diagnosis or strong clinical suspicion"] Measurement technique Confirm with laboratory Codes LOINC: 94420-0 ICD-10: Z08.0 Clinical summary This test analyzes circulating tumor DNA (ctDNA) in a blood sample using Next Generation Sequencing (NGS) to provide a genomic profile for cancer management.
TEST-54 OncoPro PD‑L1 Circulating Tumor Cells Test This test quantifies PD‑L1 protein expression on circulating tumor cells (CTCs) isolated from a blood sample.	8 mL whole blood in EDTA preservative tube	21 working days	5,900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PD‑L1 protein expression", "Circulating Tumor Cells (CTCs)"] Parameters [] Preparation ["No fasting required", "Avoid refrigerating or freezing the sample"] Indications ["Guiding immunotherapy decisions for lung, breast, and urothelial cancers", "Predicting response to immune checkpoint inhibitors"] Measurement technique Confirm with laboratory Codes LOINC: 96314-1 ICD-10: C34.9 Clinical summary This test quantifies PD‑L1 protein expression on circulating tumor cells (CTCs) isolated from a blood sample.

Category overview

Liquid Biopsy: overview

Monitoring a cancer diagnosis safely and comfortably demands the most advanced tools available, giving you the profound reassurance of a deeply targeted, non-invasive care plan. Under our Molecular Diagnostics umbrella, our Liquid Biopsy testing employs highly sensitive next-generation sequencing to evaluate circulating tumor DNA directly from a simple blood draw. Instead of providing a definitive standalone diagnosis, this expansive molecular data serves as a powerful foundational tool for your oncology team, delivering the clarity needed for personalized medical guidance, real-time therapy tracking, and early detection of resistance. Renowned as a top-tier choice among diagnostic labs in the UAE, DNA Labs UAE ensures strict patient privacy and consistently rapid, highly accurate results. Empower your personalized oncology strategy: explore our liquid biopsy testing in the UAE below to book your test, arrange a gentle home collection, or consult our expert team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.